Showing results (601-610 of 1,786) with videos related to

Sort By:
Pageof 179
European Journal of Gastroenterology & Hepatology|March 1, 1996
Hyperglycaemia affects proximal gastric motor and sensory function in normal subjectsG S Hebbard, W M Sun, J Dent, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1992
Indium-111-leukocyte and gallium-67 imaging in acute sarcoidosis: report of two patientsC J Palestro, B Schultz, M Horowitz, et al.
The Journal of Biological Chemistry|November 16, 2002
Active rhodanese lacking nonessential sulfhydryl groups contains an unstable C-terminal domain and can be bound, inactivated, and reactivated by GroELJesse Ybarra, Anusri Mitra Bhattacharyya, Markandeswar Panda, et al.
Journal of Public Health Dentistry|March 29, 2000
Oral cancer educational materials for the general public: 1998V Chung, A M Horowitz, M T Canto, et al.
Alimentary Pharmacology & Therapeutics|January 3, 2001
Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitusP Bytzer, N J Talley, M P Jones, et al.
The Journal of Reproductive Medicine|August 19, 2000
Postablative risk of endometrial carcinoma in New Zealand white rabbits given high-dose estrogenG M Horowitz, S Christensen, C Kennebeck, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 18, 2000
Changes in cardiac mechanics with heat acclimation: adrenergic signaling and SR-Ca regulatory proteinsE Mirit, C Gross, Y Hasin, et al.
The Journal of Biological Chemistry|March 18, 1994
Mutation of cysteine 254 facilitates the conformational changes accompanying the interconversion of persulfide-substituted and persulfide-free rhodaneseT A Islam, D M Miller-Martini, P M Horowitz
The Journal of Biological Chemistry|February 4, 1994
Mutations of noncatalytic sulfhydryl groups influence the stability, folding, and oxidative susceptibility of rhodaneseD M Miller-Martini, J M Chirgwin, P M Horowitz
Clinical Transplants|August 7, 2014
2013 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disordersMarcelo Pasquini, Zhiwei Wang, Mary M Horowitz, et al.
Pageof 179